First reported by Seoul Economic Daily
LG Chem Partners with Chinese Biotech to Develop Cancer Drugs
LG Chem partners with China's OTR to develop cancer drugs
By
The Korea Herald
9h ago
Source
The Korea HeraldLG Chem partners with China's OTR to develop cancer drugskoreaherald.comLG Chem said Wednesday it has signed a strategic partnership with Shanghai-based OTR Therapeutics to identify and develop promising oncology drug candidates, strengthening its push into China's fast-growing biotechnology sector. OTR Therapeutics is a biotechnology company that combines in-house research with open innovation to discover and develop treatments for cancer, immunological and inflammatory diseases, and metabolic disorders. Under the agreement, LG Chem will leverage OTR's drug discove
You might also wanna read
LG Chem Partners with Chinese Biotech to Develop Cancer Drugs
Seoul Economic Daily·11h ago
Traitements contre le cancer : «La Chine est en train de devenir le leader mondial du médicament»
l.liberation.fr·1mo ago
China creates new regulatory pathway to accelerate access to advanced biomedical therapies
China has established a new regulatory "tech track" for advanced therapies like personalized cancer treatments, cell and gene therapies, and
biopharmadive.com·23d ago
OHSU advances massive leap in medical science with cellular therapies
Oregon Health & Sciences University·11d ago
China's biotech rise: A case study in multiple myeloma drug development
This article examines China's rapid advancement in biotechnology through the lens of a multiple myeloma drug development case study. It disc
writingruxandrabio.com·15d ago
New drug for cancer patients with ‘limited’ treatment options enters clinical trial
The Independent·2d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.